Mass spectrometry-based proteomic analysis to characterize cisplatin induced early signaling events in head and neck squamous cell carcinoma

Ankit P. Jaina Institute of Bioinformatics, International Technology Park, Bangalore, IndiaView further author information

Vivek Ghosea Institute of Bioinformatics, International Technology Park, Bangalore, India;b Manipal Academy of Higher Education (MAHE), Manipal, IndiaView further author information

Srijon Munshia Institute of Bioinformatics, International Technology Park, Bangalore, IndiaView further author information

Firdous A. Bhatc Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USAView further author information

Gourav Deya Institute of Bioinformatics, International Technology Park, Bangalore, IndiaView further author information

Vishalakshi Nanjappaa Institute of Bioinformatics, International Technology Park, Bangalore, India;b Manipal Academy of Higher Education (MAHE), Manipal, IndiaCorrespondence[email protected]

https://orcid.org/0000-0003-0009-3158 View further author information

Mass spectrometry-based proteomic analysis to characterize cisplatin induced early signaling events in head and neck squamous cell carcinoma

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Mass spectrometry-based proteomic analysis to characterize cisplatin induced early signaling events in head and neck squamous cell carcinoma

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date